Article

Article detail, metadata, authors, and available full-text links.

Paper reader

Loading paper...

article · 2025

Comparative Analysis of Clinical Efficacy and Safety of Pyrotinib Plus Capecitabine versus Trastuzumab Emtansine (T-DM1) as Second-Line Treatment for HER2-Positive Advanced Breast Cancer: A Retrospective Study

Hao Han, Congcong Wang, Fenge Jiang, Ping Sun, Jiannan Liu

Pyrotinib plus capecitabine significantly improves median PFS compared to T-DM1 in patients with HER2-positive advanced breast cancer, demonstrating a favora...

1 citationsDrug Design Development and TherapyDOI: https://doi.org/10.2147/dddt.s516394Open accessPDF reported by metadataFull text reported by metadata
Comparative Analysis of Clinical Efficacy and Safety of Pyrotinib Plus Capecitabine versus Trastuzumab Emtansine (T-DM1) as Second-Line Treatment for HER2-Positive Advanced Breast Cancer: A Retrospective Study